Bacosides from Bacopa monnieri extract: An overview of the effects on neurological disorders.
Bacopa monnieri
bioactive
complementary and alternative medicines
neurological disorders
nootropic
phytochemical
Journal
Phytotherapy research : PTR
ISSN: 1099-1573
Titre abrégé: Phytother Res
Pays: England
ID NLM: 8904486
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
revised:
04
06
2021
received:
21
11
2020
accepted:
08
06
2021
pubmed:
14
7
2021
medline:
27
10
2021
entrez:
13
7
2021
Statut:
ppublish
Résumé
From ancient history, complementary and alternative medicines have played a significant role as holistic therapeutic treatments of various human diseases including cancer, diabetes, neurological diseases, and skin problems. One Indian medicinal plant (herb), Bacopa monnieri has been used in many parts of the world as such medicine, particularly for the treatment of various neurological disorders. It is well known as a potent "tonic for the human brain," which serves as a memory enhancer. Multiple studies proved that this herb contains a plethora of potential bioactive, phytochemical compounds with synergistic properties. The main purpose of the present review is to shed light on the use of Bacopa monnieri and its active principles (bacosides) in the management of neurological disorders. Furthermore, the signaling pathways modulated by bacosides have been critically discussed in this review. Moreover, we have critically summarized the present knowledge of this perennial creeping herb based upon the literature mining from different scientific engines.
Substances chimiques
Plant Extracts
0
Triterpenes
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
5668-5679Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Agarwal, S., Chaudhary, B., & Bist, R. (2017). Protective propensity of bacoside A and bromelain on renal cholinesterases, γ-aminobutyric acid and serotonin level of Mus musculus intoxicated with dichlorvos. Chemico-biological interactions, 261, 139-144.
Anabarasi, K., Kathirvel, G., Vani, G., Jayaraman, G., & Devi, C. S. S. (2006). Cigarette smoking induces heat shock protein 70 kDa expression and apoptosis in rat brain: Modulation by bacoside A. Neuroscience, 138(4), 1127-1135.
Anabarasi, K., Vani, G., Balakrishna, K., & Devi, C. S. S. (2005a). Creatine kinase isoenzyme patterns upon chronic exposure to cigarette smoke: Protective effect of Bacoside A. Vascular Pharmacology, 42(2), 57-61.
Anabarasi, K., Vani, G., Balakrishna, K., & Devi, C. S. S. (2005b). Effect of bacoside A on membrane-bound ATPases in the brains of rats exposed to cigarette smoke. Journal of Biochemical and Molecular Toxicology, 19(1), 59-65.
Anabarasi, K., Vani, G., Balakrishna, K., & Devi, C. S. S. (2006). Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats. Life Sciences, 78(12), 1378-1384.
Anand, A., Saraf, M. K., & Prabhakar, S. (2010). Antiamnesic effect of B. monniera on L-NNA induced amnesia involves Calmodulin. Neurochemical Research, 35(8), 1172-1181.
Anand, A., Tyagi, R., Mohanty, M., Goyal, M., & Silva Wijekoon, N. (2015). Dystrophin induced cognitive impairment: Mechanisms, models and therapeutic strategies. Annals of Neurosciences, 22(2), 108.
Anand, T., Pandareesh, M. D., Bhat, P. V., & Venkataramana, M. (2014). Anti-apoptotic mechanism of bacoside rich extract against reactive nitrogen species induced activation of iNOS/Bax/caspase 3 mediated apoptosis in L132 cell line. Cytotechnology, 66, 823-838.
Angelopoulos, T., Scordilis, D. M., & Tsagkaris, C. (2019). Cognitive Impairment and Rehabilitation in Alzheimer's Disease. In In Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease (pp. 1-30). Singapore: Springer.
Apetz, N., Munch, G., Govindaraghavan, S., & Gyengesi, E. (2014). Natural compounds and plant extracts as therapeutics against chroic inflammation in Alzheimer's disease-a translational perspective. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 13(7), 1175-1191.
Bansai, M., Kumar, A., & Reddy, M. S. (2014). Influence of Agrobacterium rhizogenes strains on hairy root induction and ‘bacoside A’ production from Bacopa monnieri (L.) Wettst. Acta Physiologiae Plantarum, 36(10), 2793-2801.
Benhardi, R. V., Tichauer, J. E., & Eugenín, J. (2010). Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. Journal of Neurochemistry, 112(5), 1099-1114.
Bhardwaj, P., Goswami, N., Narula, P., Jain, C. K., & Mathur, A. (2018). Zinc oxide nanoparticles (ZnO NP) mediated regulation of bacosides biosynthesis and transcriptional correlation of HMG-CoA reductase gene in suspension culture of Bacopa monnieri. Plant Physiology and Biochemistry, 130, 148-156.
Bhardwaj, P., Jain, C. K., & Mathur, A. (2018). Comparative evaluation of four triterpenoid glycoside saponins of bacoside A in alleviating sub-cellular oxidative stress of N2a neuroblastoma cells. Journal of Pharmacy and Pharmacology, 70(11), 1531-1540.
Cauffield, J. S., & Chen, J. J. (2019). Neurological conditions. In Principles and practice of botanicals as an integrative therapy (p. 203). Boca Raton, FL: CRC Press.
Chandrasekhar, S. (2020). Gene expression of tyrosine hydroxylase and glutamate receptors GluR1 and NR1 in striatal neurons of Parkinsonian rats and modulatory effect of Bacoside-A, a principle constituent of Bacopa monnieri Linn. International Journal of Applied Biology and Pharmaceutical Technology, 11(2), 83-104.
Chandrasekhar, S., Thangaranjan, S., Loganathan, S., Sundaram, S., & Kumarasamy, P. (2013). Molecular docking studies of Bacoside-A, an active component of Bacopa monnieri with DJ1 for anti-Parkinson's drug design. Biomirror, 4(9), 1-4.
Charoenphon, N., Anandsongvit, N., Kosai, P., Sirisidthi, K., Kangwanrangsan, N., & Jiraungkoorskul, W. (2016). Brahmi (Bacopa monnieri): Up-to-date of memory boosting medicinal plant:A review. Indian Journal of Agricultural Research, 50(1), 1-7.
Chaturvedi, P. A., & Hingorani, L. (2018). Media standardization for enhanced production of bacoside of Bacopa monnieri in situ condition. Pharmacognosy Magazine, 14(55), 32.
Chaudhary, B., & Bist, R. (2017). Protective manifestation of bacoside A and bromelain in terms of cholinesterases, gamma-amino butyric acid, serotonin level and stress proteins in the brain of dichlorvos-intoxicated mice. Cell Stress & Chaperones, 22(3), 371-376.
Chaudhuri, K. S., Tiwari, N. R., Tiwari, R. R., & Sharma, R. S. (2017). Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer's disease. Annals of Neurosciences, 24(2), 111-122.
Chauhan, N. B., & Mehla, J. (2015). Ameliorative effects of nutraceuticals in neurological disorders. In R. R. Watson & V. R. Preedy (Eds.), Bioactive nutraceuticals and dietary supplements in neurological and brain disease (pp. 245-260). Amsterdam, The Netherlands: Elsevier.
Das, K. (2019). Role of triterpenoid glycosides on axonal protection in multiple sclerosis and experimental autoimmune encephalomyelitis. RGUHS.
Deepak, M., & Amit, A. (2004). The need for establishing identities of ‘bacoside A and B’, the putative major bioactive saponins of Indian medicinal plant Bacopa monnieri. Phytomedicine, 11(2/3), 264-268.
Deepak, M., & Amit, A. (2013). ‘Bacoside B’-the need remains for establishing identity. Fitoterapia, 87, 7-10.
Dethe, S., Deepak, M., & Agarwal, A. (2016). Elucidation of molecular mecganism(s) of cognition enhancing activity of Bacomind: A standardized extract of Bacopa monnieri. Pharmacognosy Magazine, 12(Suppl 4), S482-S487.
Dowell, A., Davidson, G., & Ghosh, D. (2015). Validation of quantitative HPLC method for Bacosides in Keenmind. Evidence-based Complementary and Alternative Medicine, 2015, 696172.
Dubey, T., & Chinnathambi, S. (2019). Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease. Archives of Biochemistry and Biophysics, 676, 108-153.
Giri, A. K., & Khan, K. A. (1996). Chromosome aberrations, sister chromatid exchange and micronuclei formation analysis in mice after in vivo exposure to bacoside A and B. Cytologia, 61(1), 99-103.
Goyal, K., Konar, A., Kumar, A., & Koul, V. (2020). Bacosides encapsulated in Lactoferrin conjugated PEG-PLA-PCL-OH based polymersomes act as epigenetic modulator in chemically induced amnesia. Neurochemical Research, 45(4), 796-808.
Gubbannavar, J. S., Chandola, H., Kalyani, R., & Shukla, V. J. (2012). A study to evaluate Bacoside A in Brahmi Ghrita by HPTLC method. International Journal of Green Pharmacy, 6(3), 184-186.
Hegazi, G., Taha, H., Monem, A., Sharaf, M., & Elaish, S. R. (2017). Enhancing in vitro production of bacoside A from Bacopa monnieri using precursor and elicitors feeding. Journal of Basic and Applied Scientific Research, 7, 27-35.
Hota, S. K., Barhwal, K., Baitharu, I., Prasad, D., Singh, S. B., & Ilavazhagan, G. (2009). Bacopa monniera leaf extract ameliorates hypobaric hypoxia induced spatial memory impairment. Neurobiology of Disease, 34(1), 23-39.
Jadiya, P., Khan, A., Sammi, S. R., Kaur, S., Mir, S. S., & Nazir, A. (2011). Anti-Parkinsonian effects of Bacopa monnieri: Insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease. Biochemical and Biophysical Research Communications, 413(4), 605-610.
Jain, C., Gupta, A., Tiwari, A., Sharma, V., Kumar, V., Mathur, A., & Sharma, S. (2013). Molecular docking studies of bacoside from Bacopa monnieri with LRRK2 receptor. Biologia, 68(6), 1068-1071.
Jain, P., & Kulshreshtha, D. K. (1993). Bacoside A1, a minor saponin from Bacopa monnieri. Phytochemistry, 33(2), 449-451.
Jamal, Q. M. S., Alharbim, A. H., Lohani, M., Siddiqui, M. U., Ahmad, V., Dhasmana, A., … Kesari, K. K. (2019). Elucidation of scavenging properties of nanoparticles in the prevention of carcinogenicity induced by cigarette smoke carcinogens: An in silico study. In Networking of mutagens in environmental toxicology (pp. 171-183). Cham: Springer International Publishing.
Javed, H., Meeran, N., Fizur, M., Azimullah, S., Adem, A., Sadek, B., & Ojha, S. K. (2019). Plant extracts and phytochemicals targeting α-Synuclein aggregation in Parkinson's disease models. Frontiers in Pharmacology, 9, 1555.
Jose, S., Sowmya, S., Cinu, T. A., Aleykutty, N. A., Thomas, S., & Souto, E. B. (2014). Surface modified PLGA nanoparticles for brain targeting of Bacoside-A. European Journal of Pharmaceutical Sciences, 63, 29-35.
Jyoti, A., & Sharma, D. (2006). Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicology, 27(4), 451-457.
Kamkaew, N., Paracha, T. U., Ingkaninan, K., Waranuch, N., & Chootip, K. (2019). Vasodilatory effects and mechanisms of action of Bacopa monnieri active compounds on rat mesenteric arteries. Molecules, 24(12), 2243.
Komali, E., Venkataramiah, C., & Rajendra, W. (2018). Anticonvulsant effect of Bacopa monnieri extracts on catecholamine metabolism during PTZ-induced epilepsy in different brain regions of albino rat. Research Journal of Pharmacy and Technology, 11(4), 1592-1598.
Komali, E., Venkataramiah, C., & Rajendra, W. (2020). Antiepileptic potential of Bacopa monnieri in the rat brain during PTZ-induced epilepsy with reference to cholinergic system and ATPases. Journal of Traditional and Complementary Medicine, 11(2), 137-143.
Kunte, K. B., & Kuna, Y. (2013). Neuroprotective effect of Bacopa monnieri on memory deficits and ATPase system in Alzheimer's disease (AD) induced mice. Journal of Scientific and Innovative Research, 2(4), 719-735.
Le, X. T., Pham, H. T. N., Nguyen, T. V., Nguyen, K. M., Tanaka, K., Fujiwara, H., & Matsumoto, K. (2015). Protective effects of Bacopa monnieri on ischemia-induced cognitive deficits in mice: The possible contribution of bacopaside I and underlying mechanism. Journal of Ethnopharmacology, 167, 37-45.
Leonard, J. (2016). Production of Bacoside A-A potent herbal drug for Alzheimer in callus cultures of Bacopa monnieri (L.) Pennell.
Madhu, K., Prakash, T., & Maya, S. (2019). Bacoside-A inhibits inglammatory cytokines and chemokine in experimental immune encephalomyelitis. Biomedicine & Pharmacotherapy, 109, 1339-1345.
Malishev, R., Shaham-Niv, S., Nandi, S., Kolusheva, S., Gazit, E., & Jelinek, R. (2017). Bacoside-A, an Indian traditional-medicine substance, inhibits ß-amyloid cytotoxicity, fibrillation, and membrane interactions. ACS Chemical Neuroscience, 8(4), 884-891.
Mamidala, M. P., Rajesh, N., & Rajesh, V. (2016). Mass spectrometric evaluation of neurotransmitter levels in OMR 32 cell line in response to Ayurvedic medicines. Rapid Communications in Mass Spectrometry, 30(12), 1413-1422.
Mathew, J., Balakrishnan, S., Antony, S., Abraham, P. M., & Paulose, C. S. (2012). Decreased GABA receptor in the cerebral cortex of epileptic rats: The effect of Bacopa monnieri and Bacoside-A. Journal of Biomedical Science, 19(1), 1-13.
Mathew, J., Gangadharan, G., Kuruvilla, K. P., & Paulose, C. S. (2011). Behavioral deficit and decreased GABA receptor functional regulation in the hippocampus of epileptic rats: Effect of Bacopa monnieri. Neurochemical Research, 36(1), 7-16.
Mathew, J., Paul, J., Nandhu, M. S., & Paulose, C. S. (2010). Bacopa monnieri and Bacoside-A for ameliorating epilepsy associated behavioral deficits. Fitoterapia, 81(5), 315-322.
Mishra, A., Mishra, A. K., & Jha, S. (2018). Effect of traditional medicine brahmi vati and bacoside A-rich fraction of Bacopa monnieri on acute pentylenetetrzole-induced seizures, amphetamine-induced model of schizophrenia, and scopolamine-induced memory loss in laboratory animals. Epilepsy and Behavior, 80, 144-151.
Naik, P. M., Manohar, S. H., Praveen, N., & Murthy, H. N. (2010). Effects of sucrose and pH levels on in vitro shoot regeneration from leaf explants of Bacopa monnieri and accumulation of bacoside A in regenerated shoots. Plant Cell, Tissue and Organ Culture (PCTOC), 100(2), 235-239.
Nemetchek, M. D., Stierle, A. A., Stierle, D. B., & Lurie, D. I. (2017). The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. Journal of Ethnopharmacology, 197, 92-100.
Pandey, S. P., Singh, H. K., & Prasad, S. (2015). Alterations in hippocampal oxidative stress, expression of AMPA receptor GluR2 subunit and associated spatial memory loss by Bacopa monniera extract (CDRI-08) in Streptozotocin-induced diabetes mellitus type 2 mice. PLoS One, 10(7), e0131862.
Paulose, C. S., Chathu, F., Khan, S. R., & Krishnakumar, A. (2008). Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: Glutamate receptor gene expression. Neurochemical Research, 33(9), 1663-1671.
Pawar, S. S., & Jadhav, M. G. (2015). Determination and quantification of bacoside A from Bacopa monnieri L. by high performance thin layer chromatography. International Journal of Pharmacognosy and Phytochemical Research, 7(5), 1060-1065.
Raghav, S., Singh, H., Dalal, P. K., Srivastava, J. S., & Asthana, O. P. (2006). Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment. Indian Journal of Psychiatry, 48(4), 238-242.
Rai, K., Gupta, N., Dharamdasani, L., Nair, P., & Bodhankar, P. (2017). Bacopa monnieri: A wonder drug changing fortune of people. International Journal of Applied Sciences and Biotechnology, 5(2), 127-132.
Ramasamy, S., Chin, S. P., Sukumar, S. D., Buckle, M. J. C., Kiew, L. V., & Chung, L. Y. (2015). In silico and in vitro analysis of bacoside A aglycones and its derivatives as the constituents responsible for the cognitive effects of Bacopa monnieri. PLoS One, 10(5), e0126565.
Rastogi, M., Ojha, R. P., Prabu, P. C., Devi, B. P., Agrawal, A., & Dubey, G. P. (2012). Amelioration of age associated neuroinflammation on long term bacosides treatment. Neurochemical Research, 37(4), 869-874.
Rastogi, S., & Kulshreshtha, D. K. (1998). Bacoside A2-A triterpenoid saponin from Bacopa monnieri. Indian Journal of Chemistry 38B, 30(41):353-356.
Rastogi, S., Pal, R., & Kulshreshtha, D. K. (1994). Bacoside A3: A triterpenoid saponin from Bacopa monnieri. Phytochemistry, 36(1), 133-137.
Rauf, K., Subhan, F., Abbas, M., Haq, I. u., Ali, G., & Ayaz, M. (2012). Effect of acute and sub chronic use of Bacopa monnieri on dopamine and serotonin turnover in mice whole brain. African Journal of Pharmacy and Pharmacology, 6(39), 2767-2774.
Russo, A., Borrelli, F., Campisi, A., Acquaviva, R., Ractiti, G., & Vanella, A. (2003). Nitric oxide-related toxicity in cultured astrocytes: Effect of Bacopa monniera. Life Sciences, 73(12), 1517-1526.
Sandhya, T., Sowjanya, J., & Veeresh, B. (2012). Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochemical Research, 37(5), 1121-1131.
Saraf, M. K., Anand, A., & Prabhakar, S. (2010). Scopolamine induced amnesia is reversed by Bacopa monniera through participation of kinase-CREB pathway. Neurochemical Research, 35(2), 279-287.
Saraf, M. K., Prabhakar, S., Pandhi, P., & Anand, A. (2008). Bacopa monniera ameliorates amnesic effects of diazepam qualifying behavioral-molecular partitioning. Neuroscience, 155(2), 476-484.
Saraf, M. K., Prabhakar, S., Khanduja, K. L., & Anand, A. (2011). Bacopa monniera attenuates scopolamine-induced impairment of spatial memory in mice. Evidence-based Complementary and Alternative Medicine, 2011, 236186.
Sekhar, V. C., Vishwanathan, G., & Baby, S. (2019). Insights into the molecular aspects of Neuroprotective Bacoside A and Bacopaside I. Current Neuropharmacology, 7(5), 438-446.
Shahid, M., Subhan, F., Ullah, I., Ali, G., Alam, J., & Shah, R. (2016). Beneficial effects of Bacopa monnieri extract on opioid induced toxicity. Heliyon, 2(2), e00068.
Siddique, Y. H., Mujtaba, S. F., Faisal, M., Jyoti, S., & Naz, F. (2014). The effect of Bacopa monnieri lef extract on dietary supplementation in transgenic Drosophila model of Parkinson's disease. European Journal of Integrative Medicine, 6(5), 571-580.
Singh, A. P. (2003). The role of natural products in pharmacotherapy of Alzheimer's disease. Ethnobotanical Leaflets, 2003(1), 15.
Singh, B., Mahdi, A. A., & Pandey, S. (2014). Bacopa monnieri promoter of antioxidant property in MPTP-induced Parkinson's disease. International Journal of Scientific and Innovative Research, 2(2), 1-7.
Singh, B., Pandey, S., Verma, R., Ansari, J. A., & Mahdi, A. A. (2016). Comparative evaluation of extract of Bacopa monnieri and Mucuna pruriens as neuroprotectant in MPTP model of Parkinson's disease. Indian Journal of Experimental Biology, 54(11), 758-766.
Sivaraman, D., Anbu, N., Kabilan, N., Kumar, M. P., Shanmugapriya, P., & Christian, G. J. (2019). Review on current treatment strategy in Alzheimer's disease and role of herbs in treating neurological disorders. International Journal of Translational Research in Indian Medicine, 1, 33-43.
Srimachai, S., Devaux, S., Demougeot, C., Kumphune, S., Ullrich, N. D., & Chootip, K. (2017). Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury. BMC complementary and alternative medicine, 17(1), 1-10.
Srivastava, P., Raut, H. N., Puntambekar, H. M., & Desai, A. C. (2012). Stability studies of crude plant material of Bacopa monnieri and quantitative determination of Bacopaside I and Bacoside A by HPLC. Phytochemical Analysis, 23(5), 502-507.
Suganthy, N., Pandian, K. S., & Devi, K. P. (2009). Cholinesterase inhibitors from plants: Possible treatment strategy for neurological disorders-a review. International Journal of Biomedicine and Pharmaceutical Sciences, 3, 87-103.
Sumathi, T., Nathiya, V. C., & Sakthikumar, M. (2011). Protective effect of bacoside-A against morphine-induced oxidative stress in rats. Indian Journal of Pharmaceutical Sciences, 73(4), 409-415.
Suseela, P., Swathi, G., & Rajendra, W. (2013). Anticonvulsant effect of different extracts of Bacopa monnieri on cholinergic metabolism during pentylenetetrazole-induced epilepsy. International Journal of Pharma and Bio Sciences, 3, 194-200.
Swathi, G., Bhuvaneswar, C., & Rajendra, W. (2013). Alterations of cholinergic neurotransmission in rotenone induced Parkinson's disease: Protective role of Bacopa monnieri. International Journal of Pharma and Bio Sciences, 3, 286-292.
Thomas, R. B., Joy, S., Ayajan, M. S., & Paulose, C. S. (2013). Neuroprotective potential of Bacopa monniera and Bacoside A against dopamine receptor dysfunction in the cerebral cortex of neonatal Hypoglycaemic rats. Cellular and Molecular Neurobiology, 33(8), 1065-1074.
Uabundit, N., Wattanathorn, J., Mucimapura, S., & Ingkaninan, K. (2010). Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model. Journal of Ethnopharmacology, 127(1), 26-31.
Vani, G., Anabarasi, K., & Shyamaladevi, C. S. (2015). Bacoside A: Role in cigarette smoking induced changes in brain. Evidence-based Complementary and Alternative Medicine, 2015, 286137.
Vishwakarma, R. K., Kumari, U., & Khan, B. M. (2016). Memory booster plant Bacopa monniera (Brahmi): Biotechnology and molecular aspects of Bacoside biosynthesis. In Medicinal Plants-Recent Advances in Research and Development (pp. 167-189). Singapore: Springer.
Watthanasuebsin, P., & Sittiprapaporn, P. (2017). Effect of Brahmi extract on human brainwaves. Paper presented at: 2017 International Conference on Digital Arts, Media and Technology (ICDAMT). 364-368.
Wu, Y., Chen, M., & Jiang, J. (2019). Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion, 49, 35-45.
Yadav, M., Parle, M., Sharma, N., Ghimire, K., & Khare, N. (2016). Role of bioactive phytoconstituents from several traditional herbs as natural neuroprotective agents. Inventi Rapid: Planta Activa, 2016(4), 1-4.
Yamcheun, P., Chaiwang, N., Lapphanichayakool, P., Inhkaninan, K., & Limpeanchob, N. (2017). Neuroprotective effect of Bacopa monnieri extract on oxidized low density lipoprotein-induced neurotoxicity in SH-SY5Y neuroblastoma cells. The Journal of Pharmacology, 39(1), 5-18.